What is the recommended dose of Procardia (nifedipine) for a patient with hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Procardia (Nifedipine) Dosing for Hypertension

Immediate-release nifedipine (Procardia capsules) should NOT be used for treating elevated blood pressure in asymptomatic patients, as it poses significant risks including hypotension, myocardial ischemia, stroke, and death. 1

Critical Safety Warning

The immediate-release nifedipine capsule formulation is contraindicated for hypertension management and should never be prescribed for this indication. 1 Multiple case reports document serious adverse events including:

  • Acute myocardial infarction 1
  • Cardiac ischemia and ECG changes 1
  • Severe hypotension 1
  • Ventricular arrhythmias 2
  • Stroke and death 1

The British Hypertension Society explicitly states that "nifedipine in capsule form should no longer be prescribed." 1

Extended-Release Nifedipine Dosing (If Appropriate)

For chronic hypertension management, only extended-release nifedipine formulations should be used, starting at 30 mg once daily and titrating up to 60-90 mg once daily as needed. 3

Dosing Protocol:

  • Initial dose: 30 mg once daily (extended-release) 3
  • Titration: Increase to 60 mg once daily after 7-14 days if blood pressure remains uncontrolled 3
  • Maximum dose: 90 mg once daily 3
  • Allow 4 weeks between dose adjustments to observe full therapeutic response 1

High-Dose Regimens for Refractory Cases:

For patients with pulmonary arterial hypertension who demonstrate acute vasoreactivity, doses up to 120-240 mg/day have been used, though this is not standard for systemic hypertension. 1

When Nifedipine Should NOT Be Used

Avoid nifedipine in the following situations:

  • Asymptomatic hypertension in the emergency department - rapid blood pressure lowering provides no benefit and increases harm 1
  • Without concurrent beta-blocker therapy when using any dihydropyridine for acute coronary syndromes 1
  • Heart failure or severe left ventricular dysfunction - use verapamil or diltiazem instead if a calcium channel blocker is needed 1
  • Urgent/emergent hypertension - use intravenous agents that can be titrated (not oral nifedipine) 2

Preferred Approach for Elevated Blood Pressure

For patients with blood pressure ≥160/100 mmHg, initiate combination therapy with two drugs rather than monotherapy with nifedipine. 4 The preferred combinations are:

  • ACE inhibitor or ARB + dihydropyridine calcium channel blocker (extended-release nifedipine or amlodipine) 4
  • ACE inhibitor or ARB + thiazide/thiazide-like diuretic 4

Single-pill combination therapy improves adherence and achieves blood pressure control more rapidly. 4

Key Clinical Pitfalls

  • Never use immediate-release nifedipine capsules for hypertension - this formulation causes unpredictable, rapid blood pressure drops 1
  • Do not treat asymptomatic hypertension acutely - blood pressure often decreases spontaneously by 6-12% without intervention, and rapid lowering causes more harm than benefit 1
  • Avoid in elderly patients without dose adjustment - bioavailability is 70% higher and half-life is nearly doubled in patients >60 years 3
  • Do not combine with grapefruit juice - this increases nifedipine levels 2-fold via CYP3A4 inhibition 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ventricular arrhythmia following short-acting nifedipine administration.

Pediatric nephrology (Berlin, Germany), 2005

Guideline

Treatment of Severe Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.